Skip to main content
Dec 29, 2025
Blog
The JPM Playbook: Strategic Pillars for Life Sciences Success in 2026
By Chris Brinzey
Dec 16, 2025
Blog
The Integrated Advantage at JPM: Why Coordinated Communications Strategy Wins
By Ally Stubin, Vice President
Dec 4, 2025
Blog
For Biotech Firms, Building Credibility and Investor Confidence Should Start Long Before the First Major Milestone
By
Nov 26, 2025
Blog
From Jefferies and ICR Healthcare Conference to JPM: Six Messaging Lessons That Win Investor Attention
By Jessica Hodgson and Kris Lam
Nov 5, 2025
Blog
Why Life Sciences Companies Must Maintain IPO-Ready Strategic Communications Despite Market Headwinds
Nov 4, 2025
Blog
Generative Engine Optimization (GEO): Strategic Imperatives for Health Sector Leaders
By Kris Lam
Oct 2, 2025
Blog
Convertible Market Strength and Healthcare Momentum: Recent Deals with Celcuity, Ligand, and Oscar Health
By Kristina Woodhouse
Sep 30, 2025
Blog
Cancer Communications in a Volatile Cycle: Think Like Policy, Act for Patients
By Ben Shannon
Sep 18, 2025
Blog
Navigating the FDA’s New Real-Time CRL Publication Policy: Strategic Communications and Risk Management for Life Sciences Companies
By Phil Denning
Sep 2, 2025
Blog
IPO Resurgence in Perspective
By Sameer Khambadkone
Aug 18, 2025
Blog
Career Advice for Aspiring Healthcare Communications Professionals
By Harrison Wong
Jul 14, 2025
Blog
Key Insights from the 2025 Truist Digital Health Summit: Market Dynamics, Investment Themes, and IPO Readiness
By Jordan Kohnstam
Jun 9, 2025
Blog
Destigmatizing Men’s Health for Men’s Health Week
By Jonathan Edwards
May 15, 2025
Blog
Mental Health Awareness Month: How to Approach Communications for Sensitive Topics
By Alexis Feinberg
May 7, 2025
Blog
Inside the Buy Side: Practical Lessons on Corporate Access From a Leading Multi-Manager Hedge Fund
By Christopher Melito
May 6, 2025
Blog
Why Integration Matters: The Business Case for Unified Investor and Public Relations
By Apoorva Chaloori